Impact of the COVID-19 pandemic on routine childhood immunisation in Colombia.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
03 2022
Historique:
received: 04 02 2021
accepted: 28 06 2021
pubmed: 22 7 2021
medline: 3 3 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

To assess the impact of the COVID-19 pandemic on routine childhood vaccination coverage in Colombia by age group, rural/urban residence, state and vaccine type. Ecological study of official monthly vaccination records. Vaccination records from the Colombian Ministry of Health (March-October 2019 and 2020). Aggregated data for Colombian children (<12 months, n=676 153; 12-23 months, n=700 319; and 5 years, n=734 295) participating in the Expanded Program on Immunization. Proportion of eligible population receiving vaccination. Vaccination coverage showed an overall decline of approximately 14.4% from 2019 to 2020 (2019 coverage=76.0, 2020 coverage=61.6%). The greatest reduction in proportion vaccinated was observed in children <12 months of age for pneumococcal vaccine (second dose) (2019 coverage=81.4%; 2020 coverage=62.2%; 2019-2020 absolute difference, 19.2%; 95% CI 14.8% to 23.7%). For children aged 12-23 months, the proportion vaccinated for yellow fever declined by 16.4% (12.4% to 20.9%) from 78.3% in 2019 to 61.8% in 2020. Among children 5 years of age, the biggest decrease occurred for the oral polio vaccine (second dose), with a difference of 11.4% (7.1% to 15.7%) between 2019 and 2020 (73.1% and 61.7% for 2019 and 2020). We observed a statistically significant effect on vaccine coverage in rural versus urban areas for children <12 months and 5 years of age. Reduced uptake of immunisations during the COVID-19 pandemic poses a serious risk of vaccine-preventable disease outbreaks. Colombia and other middle-income countries need to continue to monitor immunisation programme coverage and disease outbreaks at the national and subnational levels and undertake catch-up vaccination activities.

Identifiants

pubmed: 34285000
pii: archdischild-2021-321792
doi: 10.1136/archdischild-2021-321792
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jose Moreno-Montoya (J)

Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia josemorenomontoya@gmail.com.

Silvia Marcela Ballesteros (SM)

Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia.

Jaid Constanza Rojas Sotelo (JC)

Ministerio de Salud y Protección Social, Gobierno de Colombia, Bogota, Colombia.

Clara Lucia Bocanegra Cervera (CL)

Ministerio de Salud y Protección Social, Gobierno de Colombia, Bogota, Colombia.

Pedro Barrera-López (P)

Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia.

José A De la Hoz-Valle (JA)

Clinical Studies and Clinical Epidemiology Division, Hospital Universitario de la Fundación Santa Fe de Bogotá, Bogota, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH